The SPRAY study (Sativex® for Pain Research in Advanced malignancY) is a medical research study looking at whether an investigational medication, Sativex®, is effective in managing persistent cancer pain in approximately 336 patients worldwide.

Investigational means it has not been approved by all the necessary regulatory agencies where this study is taking place. Sativex® has been approved in Canada as an add-on treatment for pain in patients with advanced cancer.

In this study, Sativex® comes in the form of a metered dose oro-mucosal spray (like a breath freshener), taken by spraying it inside the cheeks of your mouth. More details on how to take this study medication will be provided to you upon study entry.

Watch an online presentation: Waging War on Cancer

Experiencing constant cancer pain even with your pain medications?  If you have persistent cancer pain that is not adequately managed by your current pain medications, you may want to learn more about participating in the SPRAY study.Do you or a loved one qualify?  Find out here...

If you reside in the U.S., you may use our online screener to find out if you or someone you know may be eligible to participate in the SPRAY clinical study. You will also be able to find the study sites nearest to you. We can also be reached by calling
1-877-388-3315.

SPRAY Study Information Persistent Pain in Cancer What is a Clinical Trial? Where is the SPRAY Study Taking Place? Resources and Support